HSP90B2P and hepatocellular carcinoma: As another POC, anticancer drugs caused the release of exosomes with HSPs from human hepatocellular carcinoma cells, although the released HSP-exosomes elicited effective NK cell antitumor responses in vitro [73], suggesting an immunostimulatory role of EV-HSP.